To discover candidate proteins that can target Bod1 to kinetochores in mitotic HeLa cells, we combined affinity purification of Bod1 with label-free quantitative mass spectrometry.
BOD1 plays an important role in modulating of the cerebellar IV/V lobePCs→FNCaMKIIα+ circuit and provide therapeutic targets for the treatment of ataxia behaviors.